The Elekta Unity system consists of a high-field 1.5 Tesla MRI scanner and a linear accelerator alongside integrated real-time dose planning software for target monitoring, the Stockholm-based company said.
Elekta added that its Elekta Unity device has the ability to reshape doses based on daily changes in shape, size and the position of the tumor and surrounding healthy anatomy.
“We are pleased to have achieved this important milestone toward making Elekta Unity available in Canada and expect that this important new treatment option will become available to patients later this year, subsequent to receiving a service license from the Canadian Nuclear Safety Commission. Researchers and clinicians from the Odette Cancer Centre at Sunnybrook Health Sciences Centre and Princess Margaret Cancer Centre have played critical roles in developing and evaluating this transformative technology, and we look forward to the day when their patients and other Canadian cancer patients will have access to this transformative approach to radiation therapy,” prez & CEO Richard Hausmann said in a press release.
Last July, Elekta said that it acquired Canadian quality assurance company Acumyn for an undisclosed amount.